Zobrazeno 1 - 10
of 18
pro vyhledávání: '"F S, Laroux"'
Autor:
G Parkes, R Ungaro, S Danese, M Abreu, E Arenson, W Zhou, D Ilo, F S Laroux, H Deng, Y Sanchez Gonzalez, L Peyrin-Biroulet
Publikováno v:
Journal of Crohn's and Colitis. 16:i476-i477
Background Establishing mucosal healing (MH) as a treatment goal for ulcerative colitis (UC) requires evidence of improvement in both endoscopic and histologic assessments of the intestinal mucosa and long-term sequalae. Currently, guidelines on how
Autor:
L Peyrin-Biroulet, C Siegel, S Tanida, P Bossuyt, E Torres, M Dubinsky, F Baert, W Zhou, J Klaff, S Berg, F S Laroux, Y Sanchez Gonzalez, X Yao, Q Zhou, W Reinisch
Publikováno v:
Journal of Crohn's and Colitis. 16:i477-i478
Background Upadacitinib (UPA), an oral selective and reversible JAK inhibitor, demonstrated significantly greater efficacy compared to placebo (PBO) as treatment for moderate to severe ulcerative colitis (UC), in phase 3 induction (U-ACHIEVE and U-AC
Autor:
Ian N. Hines, Sulaiman Bharwani, Shigeyuki Kawachi, Kevin P. Pavlick, Hirohisa Harada, Matthew B. Grisham, Jason M. Hoffman, F. S. Laroux
Publikováno v:
Acta Physiologica Scandinavica. 173:113-118
A number of laboratories have sought to elucidate the role of nitric oxide (NO) in both acute and chronic inflammatory diseases. It is now well appreciated that NO can influence many aspects of the inflammatory cascade ranging from its own expression
Publikováno v:
Biochemical and Biophysical Research Communications. 244:525-530
The nitric oxide (NO)-dependent S-nitrosation of thiols to generate S-nitrosothiols has been proposed as an important pathway for the metabolism of NO in vivo. Although it has been suggested that these S-nitrosated compounds are resistant to decompos
Autor:
M Symonds, D Kimpel, Christopher G. Kevil, Davis Cp, Jonathan S. Alexander, T. H. Jackson, O Blaschuk, T Dayton, Naotsuka Okayama, S M Berney, S Hill, F S Laroux
Publikováno v:
Inflammation. 22:573-582
T-lymphocytes routinely traffic from the lymphoid and vascular compartments to the tissues during immune surveillance and inflammatory responses. This egress occurs without compromising endothelial barrier, which is maintained by tight junctions (zon
Autor:
Christopher G. Kevil, Theodore J. Kalogeris, Matthew B. Grisham, L Walsh, F S Laroux, Jonathan S. Alexander
Publikováno v:
Biochemical and Biophysical Research Communications. 238:277-279
We report a simple, sensitive and rapid method for performing Northern blotting analysis which avoids the use of toxic chemicals such as formamide and glyoxal. This technique allows sensitive detection of various transcripts from total RNA samples va
Autor:
Theodore J. Kalogeris, Elaine M. Conner, Matthew B. Grisham, Adam S. Cockrell, John W. Fuseler, F S Laroux, S. Brand, Laura Gray
Publikováno v:
Expert opinion on investigational drugs. 8(9)
Nuclear factor kappaB (NF-kappaB) is an ubiquitous transcription factor and pleiotropic regulator of numerous inflammatory and immune responses. Once activated, NF-kappaB translocates from the cytosol to the nucleus of the cell, where it binds to its
Autor:
C F, Krieglstein, W H, Cerwinka, F S, Laroux, J W, Salter, J M, Russell, G, Schuermann, M B, Grisham, C R, Ross, D N, Granger
Publikováno v:
The Journal of Experimental Medicine
Several reports have implicated reactive oxygen and nitrogen metabolites (RONS) in the initiation and/or progression of inflammatory bowel diseases (IBDs). We have investigated the role of three key RONS-metabolizing enzymes (inducible nitric oxide s
Autor:
F S, Laroux, K P, Pavlick, I N, Hines, S, Kawachi, H, Harada, S, Bharwani, J M, Hoffman, M B, Grisham
Publikováno v:
Acta physiologica Scandinavica. 173(1)
A number of laboratories have sought to elucidate the role of nitric oxide (NO) in both acute and chronic inflammatory diseases. It is now well appreciated that NO can influence many aspects of the inflammatory cascade ranging from its own expression
Autor:
F S, Laroux, M B, Grisham
Publikováno v:
Microcirculation (New York, N.Y. : 1994). 8(5)
Inflammatory bowel disease (IBD) is a chronic inflammatory condition of the intestine and/or colon of unknown etiology in which patients suffer from severe diarrhea, rectal bleeding, abdominal pain, fever, and weight loss. Active episodes of IBD are